Invesco Nasdaq Biotechnology ETF (IBBQ) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores IBBQ 4.6 out of 10 — highest on Growth (8.8), lowest on Quality (1.0). It trades at 25.4 times earnings, against its own median of 20.5. Its ten largest holdings are 46% of the fund.
What stands out in IBBQ's data
U.S. biotech and pharma firms, tracked through a Nasdaq index.
Priced at a premium to the typical biotech fund — you pay more for each dollar of earnings.
Its trailing EBITDA multiple of 19.9x sits above the category median of 16.5x, among the most expensive in the group. Profitability lags, with a 20.0% EBITDA margin.
A biotech sleeve that pairs a margin advantage with a Nasdaq-based lineup.
Why did IBBQ move this week? It rose 0.7% in the week to October 9, 2026 — Moderna and Gilead Sciences drove it
IBBQ rose 0.7% in the week to October 9, 2026. The holdings that moved it most were Moderna (+18.4%), Gilead Sciences (+4.4%) and Amgen (+2.9%); Revolution Medicines (−8.2%) pushed the other way.
How is IBBQ rated? ETF Copilot scores Invesco Nasdaq Biotechnology ETF (IBBQ) 4.6 out of 10
As of October 9, 2026, ETF Copilot scores Invesco Nasdaq Biotechnology ETF (IBBQ) 4.6 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 4.6 / 10
- Growth: 8.8 / 10
- Value: 2.0 / 10
- Risk: 2.9 / 10
- Quality: 1.0 / 10
- Return: 5.9 / 10
Is IBBQ expensive right now? It trades at 25.4 times earnings, against its own median of 20.5
As of October 9, 2026, IBBQ is more expensive than 83% of its own last 5 years.
Trailing 12 months, built from IBBQ's holdings. How we calculate this →
What's inside IBBQ?
What's inside IBBQ: Size (Large 47%, Mid 37%, Small 16%); Geography (International 11%, US 89%); AI 1.2%.
What are IBBQ's top holdings? The ten largest are 46% of the fund
Gilead Sciences, Amgen, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Illumina, Biogen, Alnylam Pharmaceuticals and Royalty Pharma are IBBQ's largest holdings, in that order.
Less concentrated than 62% of Health & Biotech ETFs.
Half of IBBQ's weight sits in its 13 largest positions, and once those weights are taken into account it behaves like 32 equally weighted holdings.
What is IBBQ's expense ratio? 0.19% a year
As of October 9, 2026, IBBQ charges 0.19% a year, yields 1.15% and holds $109M in assets across 245 positions.
| Measure | IBBQ |
|---|---|
| Expense ratio | 0.19% |
| Dividend yield | 1.15% |
| Assets under management | $109M |
| Holdings | 245 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “Invesco Nasdaq Biotechnology ETF (IBBQ) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/ibbq
ETF Copilot Pro unlocks IBBQ's price and what each holding weighs.
Try Pro free →